Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 1
2015 1
2016 1
2017 1
2019 1
2020 4
2021 6
2022 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: RICHARD
Page 1
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. Among authors: lirio ra. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Long-term safety of vedolizumab for inflammatory bowel disease.
Loftus EV Jr, Feagan BG, Panaccione R, Colombel JF, Sandborn WJ, Sands BE, Danese S, D'Haens G, Rubin DT, Shafran I, Parfionovas A, Rogers R, Lirio RA, Vermeire S. Loftus EV Jr, et al. Among authors: lirio ra. Aliment Pharmacol Ther. 2020 Oct;52(8):1353-1365. doi: 10.1111/apt.16060. Epub 2020 Sep 2. Aliment Pharmacol Ther. 2020. PMID: 32876349 Free PMC article. Clinical Trial.
Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY).
Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Danese S, Rogers R, Bornstein JD, Chen J, Schreiber S, Sands BE, Lirio RA. Peyrin-Biroulet L, et al. Among authors: lirio ra. Gastroenterology. 2021 Oct;161(4):1156-1167.e3. doi: 10.1053/j.gastro.2021.06.015. Epub 2021 Jun 16. Gastroenterology. 2021. PMID: 34144047 Free article. Clinical Trial.
Advances in Pediatric Diagnostic Endoscopy: A State-of-the-Art Review.
Lerner DG, Mencin A, Novak I, Huang C, Ng K, Lirio RA, Khlevner J, Utterson EC, Harris BR, Pitman RT, Mir S, Gugig R, Walsh CM, Fishman D. Lerner DG, et al. Among authors: lirio ra. JPGN Rep. 2022 Jul 29;3(3):e224. doi: 10.1097/PG9.0000000000000224. eCollection 2022 Aug. JPGN Rep. 2022. PMID: 37168622 Free PMC article. Review.
Response to letter to editor.
Chen J, Kisfalvi K, Girard M, Wang S, Lirio R. Chen J, et al. Among authors: lirio r. J Biopharm Stat. 2022 Sep 3;32(5):805-806. doi: 10.1080/10543406.2022.2065503. Epub 2022 May 23. J Biopharm Stat. 2022. PMID: 35605090 No abstract available.
NASPGHAN Capsule Endoscopy Clinical Report.
Friedlander JA, Liu QY, Sahn B, Kooros K, Walsh CM, Kramer RE, Lightdale JR, Khlevner J, McOmber M, Kurowski J, Giefer MJ, Pall H, Troendle DM, Utterson EC, Brill H, Zacur GM, Lirio RA, Lerner DG, Reynolds C, Gibbons TE, Wilsey M, Liacouras CA, Fishman DS; Endoscopy Committee. Friedlander JA, et al. Among authors: lirio ra. J Pediatr Gastroenterol Nutr. 2017 Mar;64(3):485-494. doi: 10.1097/MPG.0000000000001413. J Pediatr Gastroenterol Nutr. 2017. PMID: 27642781
18 results